These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 11692445)
21. Late presentation of HIV-infected individuals. Battegay M; Fluckiger U; Hirschel B; Furrer H Antivir Ther; 2007; 12(6):841-51. PubMed ID: 17926639 [TBL] [Abstract][Full Text] [Related]
22. Guidelines: opportunistic infections and HIV patients. Winslow DL AIDS Alert; 2009 Jul; 24(7):81. PubMed ID: 19705577 [No Abstract] [Full Text] [Related]
23. Management of HIV: a swing back to the future. Alozie OK; Bonham S; Henry WK Minn Med; 2009 Oct; 92(10):45-9. PubMed ID: 19916274 [TBL] [Abstract][Full Text] [Related]
24. [Antiretroviral therapy in 2004]. Jablonowski H MMW Fortschr Med; 2004 Apr; 146 Spec No 1():46-8, 50-1. PubMed ID: 15373049 [TBL] [Abstract][Full Text] [Related]
25. Patients who want to stop their medications: treatment interruptions in HIV infection. Ball SC AIDS Read; 2003 Jul; 13(7):317-9, 324, 342. PubMed ID: 12889449 [No Abstract] [Full Text] [Related]
26. Current status of opportunistic infections in patients with HIV infection in the era of highly active antiretroviral therapy. Masur H; Kaplan J Curr Clin Top Infect Dis; 2001; 21():64-82. PubMed ID: 11572162 [No Abstract] [Full Text] [Related]
27. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections]. Pozio E Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694 [TBL] [Abstract][Full Text] [Related]
28. HIV therapeutics: points from the recent literature. Laurence J AIDS Read; 2003 Jul; 13(7):305, 307. PubMed ID: 12889448 [No Abstract] [Full Text] [Related]
30. Antiretroviral rounds. When to rock the boat? Frank I; Shulman N AIDS Clin Care; 2004 Nov; 16(11):90, 94. PubMed ID: 15595166 [No Abstract] [Full Text] [Related]
31. To treat or not to treat...when that is the question. Katz M Posit Living; 1999 Sep; 8(8):9, 57. PubMed ID: 12510632 [No Abstract] [Full Text] [Related]
32. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis. Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172 [TBL] [Abstract][Full Text] [Related]
33. Complications and side effects. Alberta clinic saves lives but faces new challenges. TreatmentUpdate; 2005 Mar; 17(2):1-3. PubMed ID: 17228462 [No Abstract] [Full Text] [Related]
34. Stages in HIV infection: when to start treatment. TreatmentUpdate; 2001; 12(12):13-4. PubMed ID: 11570079 [No Abstract] [Full Text] [Related]
35. Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person. Lawn SD; Wood C; Lockwood DN Clin Infect Dis; 2003 Jan; 36(1):e5-6. PubMed ID: 12491222 [TBL] [Abstract][Full Text] [Related]
36. Opportunistic infections in the era of highly active antiretroviral therapy. Ferri RS Lippincotts Prim Care Pract; 2000; 4(1):20-8. PubMed ID: 11022517 [No Abstract] [Full Text] [Related]
37. CDC issues guidelines on treating OIs among adults. ART is cornerstone of treatment plan. AIDS Alert; 2005 Jun; 20(6):66-8. PubMed ID: 15962431 [TBL] [Abstract][Full Text] [Related]
38. Travel medicine and HIV infection. Igreja R Int J STD AIDS; 2008 Sep; 19(9):577-80. PubMed ID: 18725545 [TBL] [Abstract][Full Text] [Related]
40. Pneumonia in HIV-infected patients in the HAART era: incidence, risk, and impact of the pneumococcal vaccination. López-Palomo C; Martín-Zamorano M; Benítez E; Fernández-Gutiérrez C; Guerrero F; Rodríguez-Iglesias M; Girón-González JA J Med Virol; 2004 Apr; 72(4):517-24. PubMed ID: 14981752 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]